Frontlight ResearchEarly access
Fabry disease trials in South Korea
2 of 3 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleFabry Disease Registry & Pregnancy Sub-registry
- Where
- Busan, Daejeon, Jeju City, Seoul, Suwon, Yangsan
- People
- 9,000 worldwide
- Run by
- Genzyme, a Sanofi Company
See details and how to joinNCT00196742 - No phaseTaking peopleEffect of Agalsidase Alfa on Cardiac Inflammation in Patients With Fabry Disease: A [18F]-FDG PET-CMR Study
- Where
- Seoul
- Age
- 15 years to 75 years
- People
- 25
- Run by
- Yonsei University
See details and how to joinNCT07235709